Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas
- PMID: 29922974
- DOI: 10.1007/s10014-018-0321-4
Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas
Abstract
The radiological features of lower-grade gliomas (LGGs) classified according to isocitrate dehydrogenase (IDH) mutations and codeletion of chromosomal arms 1p and 19q (1p/19q codeletion) remain unclear. We aimed to systematically characterize the radiological features of molecularly classified LGGs using IDH and 1p/19q codeletion statuses. One hundred and one LGGs were re-classified into 36 tumors with IDH mutations (IDH-Mut), 35 tumors with IDH-Mut and 1p/19q codeletion (IDH-Mut/Codel), and 30 tumors with wildtype IDH (IDH-Wt). Calcification, heterogeneous signal intensity in T2-weighted images, and cortical invasion were significantly more frequent in IDH-Mut/Codel than in IDH-Mut and IDH-Wt tumors (calcification: 48.6 vs 5.6 and 6.7%, heterogeneity: 94.3 vs 33.3 and 50%, and cortical invasion: 94.3 vs 55.6 and 40.0%, respectively). A frontal location was significantly more frequent for IDH-Mut and IDH-Mut/Codel than for IDH-Wt tumors (52.8 and 71.4 vs 12.1%, respectively), and dense contrast-enhancement was significantly more frequent in IDH-Wt than in IDH-Mut and IDH-Mut/Codel tumors (50.0 vs 2.8 and 2.9%, respectively). In conclusion, IDH-Mut/Codel tumors were characterized by calcification, frontal location, heterogeneous signal intensity, and cortical invasion; IDH-Mut tumors differed from IDH-Wt tumors according to predominant frontal lobe location and less frequent dense enhancement patterns.
Keywords: 1p/19q codeletion; Isocitrate dehydrogenase mutations; Lower-grade glioma; Radiological features.
Similar articles
-
The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.Neurosurg Focus. 2019 Dec 1;47(6):E13. doi: 10.3171/2019.9.FOCUS19660. Neurosurg Focus. 2019. PMID: 31786548
-
Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.J Neurooncol. 2016 Sep;129(3):505-514. doi: 10.1007/s11060-016-2201-2. Epub 2016 Jul 11. J Neurooncol. 2016. PMID: 27401154
-
MRI Scoring Systems for Predicting Isocitrate Dehydrogenase Mutation and Chromosome 1p/19q Codeletion in Adult-type Diffuse Glioma Lacking Contrast Enhancement.Radiology. 2024 May;311(2):e233120. doi: 10.1148/radiol.233120. Radiology. 2024. PMID: 38713025
-
MRI and CT Identify Isocitrate Dehydrogenase (IDH)-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization.Radiology. 2020 Jan;294(1):160-167. doi: 10.1148/radiol.2019191140. Epub 2019 Nov 12. Radiology. 2020. PMID: 31714193
-
Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.Cancer Med. 2020 Jan;9(1):3-11. doi: 10.1002/cam4.2686. Epub 2019 Nov 7. Cancer Med. 2020. PMID: 31701682 Free PMC article. Review.
Cited by
-
Conventional MRI features of adult diffuse glioma molecular subtypes: a systematic review.Neuroradiology. 2021 Mar;63(3):353-362. doi: 10.1007/s00234-020-02532-7. Epub 2020 Aug 25. Neuroradiology. 2021. PMID: 32840682
-
Conventional MRI-Derived Biomarkers of Adult-Type Diffuse Glioma Molecular Subtypes: A Comprehensive Review.Biomedicines. 2022 Oct 5;10(10):2490. doi: 10.3390/biomedicines10102490. Biomedicines. 2022. PMID: 36289752 Free PMC article. Review.
-
Advanced multiparametric MRI-based scoring for isocitrate dehydrogenase mutation prediction of gliomas.Pol J Radiol. 2022 Nov 22;87:e626-e634. doi: 10.5114/pjr.2022.121549. eCollection 2022. Pol J Radiol. 2022. PMID: 36532252 Free PMC article.
-
A Comparative Study of 2 Different Segmentation Methods of ADC Histogram for Differentiation Genetic Subtypes in Lower-Grade Diffuse Gliomas.Biomed Res Int. 2020 Sep 28;2020:9549361. doi: 10.1155/2020/9549361. eCollection 2020. Biomed Res Int. 2020. PMID: 33062706 Free PMC article.
-
Radiological differences between subtypes of WHO 2016 grade II-III gliomas: a systematic review and meta-analysis.Neurooncol Adv. 2020 Apr 4;2(1):vdaa044. doi: 10.1093/noajnl/vdaa044. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 32642698 Free PMC article. Review.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical